According to the research report, the U.S. supplemental health market size is expected to touch USD 59.42 Billion by 2032, from USD 35.25 Billion in 2022, growing with a significant CAGR of 5.5% from 2023 to 2032.
The U.S. supplemental health report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global U.S. supplemental health in conjunction with the geographical landscape of this vertical have also been included in this report.
The report offers intricate dynamics about different aspects of the global U.S. supplemental health market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global U.S. supplemental health during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/3063
This study covers a detailed segmentation of the global U.S. supplemental health market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global U.S. supplemental health market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.
Key Players
- Aetna Inc.
- Allianz S.E.
- American International Group, Inc.
- Anthem, Inc.
- Assurant, Inc.
- AXA Group
- Cigna Corporation
- Humana Inc.
- MetLife, Inc.
- Zurich Insurance Group AG
Market Segmentation
By Product
- Critical Illness Insurance
- Accident Insurance
- Hospital Indemnity Insurance
- Worksite Life
- Dental
By Distribution Channel
- Direct-to-Consumer (DTC)
- Agents
- Brokers
- Others
By Demography
- Individuals Aged 65 and Above
- Individuals Aged Below 65 with an Eligible Disability
Research Methodology
The research methodology adopted by analysts for compiling the global U.S. supplemental health report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global U.S. supplemental health market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Supplemental Health Market
5.1. COVID-19 Landscape: U.S. Supplemental Health Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. U.S. Supplemental Health Market, By Product
8.1. U.S. Supplemental Health Market, by Product, 2023-2032
8.1.1 Critical Illness Insurance
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Accident Insurance
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Hospital Indemnity Insurance
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Worksite Life
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Dental
8.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 9. U.S. Supplemental Health Market, By Distribution Channel
9.1. U.S. Supplemental Health Market, by Distribution Channel, 2023-2032
9.1.1. Direct-to-Consumer (DTC)
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Agents
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Brokers
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. U.S. Supplemental Health Market, By Demography
10.1. U.S. Supplemental Health Market, by Demography, 2023-2032
10.1.1. Individuals Aged 65 and Above
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Individuals Aged Below 65 with an Eligible Disability
10.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 11. U.S. Supplemental Health Market, country Estimates and Trends Forecast
11.1. U.S.
11.1.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.1.3. Market Revenue and Forecast, by Demography (2020-2032)
Chapter 12. Company Profiles
12.1. Aetna Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Allianz S.E.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. American International Group, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Anthem, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Assurant, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. AXA Group
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Cigna Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Humana Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. MetLife, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Zurich Insurance Group AG
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments